1. Collins AJ, Foley RN, Herzog C, Chavers B, Gilbertson D, Ishani A, Kasiske B, Liu J, Mau LW, McBean M, Murray A, St Peter W, Guo H, Li Q, Li S, Li S, Peng Y, Qiu Y, Roberts T, Skeans M, Snyder J, Solid C, Wang C, Weinhandl E, Zaun D, Arko C, Chen SC, Dalleska F, Daniels F, Dunning S, Ebben J, Frazier E, Hanzlik C, Johnson R, Sheets D, Wang X, Forrest B, Constantini E, Everson S, Eggers P, Agodoa L (2009) United States Renal Data System 2008 annual data report. Am J Kidney Dis 53:S1–374
2. Khan IH (1998) Comorbidity: the major challenge for survival and quality of life in end-stage renal disease. Nephrol Dial Transpl 13(suppl 1):76–79
3. van Manen JG, Korevaar JC, Dekker FW, Boeschoten EW, Bossuyt PM, Krediet RT (2002) How to adjust for comorbidity in survival studies in ESRD patients: a comparison of different indices. Am J Kidney Dis 40:82–89
4. Khan IH, Catto GR, Edward N, Fleming LW, Henderson IS, MacLeod AM (1993) Influence of coexisting disease on survival on renal-replacement therapy. Lancet 341:415–418
5. Chandna SM, Schulz J, Lawrence C, Greenwood RN, Farrington K (1999) Is there a rationale for rationing chronic dialysis? A hospital based cohort study of factors affecting survival and morbidity. BMJ (Clin Res Ed) 318:217–223